Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis

Background: In the latest 2017 American Heart Association guidelines for Kawasaki disease (KD), there are no recommendations regarding the early administration of intravenous immunoglobulin (IVIG). Therefore, the purpose of this systematic review and meta-analysis was to investigate the effects of e...

Full description

Bibliographic Details
Main Authors:	Fan Yan, Huayong Zhang, Ruihua Xiong, Xingfeng Cheng, Yang Chen, Furong Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Series:	Frontiers in Pediatrics
Subjects:	Kawasaki disease intravenous immunoglobulin therapy coronary artery lesion coronary artery aneurysm IVIG unresponsiveness
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2020.593435/full

Similar Items

Kawasaki Disease: An Update on Diagnosis and Treatment
by: Ho-Chang Kuo, et al.
Published: (2012-02-01)

Heart Rate, Responsiveness to Intravenous Immunoglobulin, and Coronary Artery Aneurysms in Kawasaki Disease
by: Miyakoshi, Chisato
Published: (2019)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
by: Ho-Chang Kuo, et al.
Published: (2018-06-01)

Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome
by: Donato Rigante, et al.
Published: (2016-02-01)

Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease
by: Ken-Pen Weng, et al.
Published: (2012-01-01)

Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease
by: Lauren L. Ching, et al.
Published: (2020-06-01)

Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease
by: Shashaani N, et al.
Published: (2020-08-01)

Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
by: Courtney B. Crayne, et al.
Published: (2019-11-01)

Initial Intravenous γ-Globulin Treatment Failure in Iranian Children with Kawasaki Disease
by: Sara Kashef, et al.
Published: (2005-09-01)

Prediction of nonresponsiveness to medium-dose intravenous immunoglobulin (1 g/kg) treatment: an effective and safe schedule of acute treatment for Kawasaki disease
by: Kyung Pil Moon, et al.
Published: (2016-04-01)

Association between maternal age and outcomes in Kawasaki disease patients
by: Wei-Dong Huang, et al.
Published: (2019-07-01)

The expression and significance of serum caveolin-1 in patients with Kawasaki disease
by: Feng Zhu, et al.
Published: (2020-01-01)

Use of Corticosteroid in Children with Unresponsiveness to Intravenous Immunoglobulin in Kawasaki Disease
by: Abdolkarim Hamedi, et al.
Published: (2017-08-01)

Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease
by: Yunjia Tang, et al.
Published: (2021-06-01)

Difficulties in Kawasaki Disease Diagnosis and Treatment in Children
by: A. E. Dobrovanov, et al.
Published: (2021-01-01)

The Expression of Glycoprotein Genes in the Inflammatory Process of Kawasaki Disease
by: Kuang-Che Kuo, et al.
Published: (2020-12-01)

Neurological involvement in Kawasaki disease: a retrospective study
by: Xiaoliang Liu, et al.
Published: (2020-07-01)

Homozygous of MRP4 Gene rs1751034 C Allele Is Related to Increased Risk of Intravenous Immunoglobulin Resistance in Kawasaki Disease
by: Yanfei Wang, et al.
Published: (2021-03-01)

Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial
by: Saori Fukui, et al.
Published: (2021-07-01)

How Should We Classify Kawasaki Disease?
by: Edoardo Marrani, et al.
Published: (2018-12-01)

Kawasaki disease for dermatologists
by: Aman Gupta, et al.
Published: (2016-01-01)

Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
by: Aswine K. Bal, et al.
Published: (2014-10-01)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
by: Khanh-Van Y. Van Anh, et al.
Published: (2020-04-01)

Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study
by: Zhenquan Wang, et al.
Published: (2018-02-01)

Review of Kawasaki Disease
by: Rani Shah, et al.
Published: (2018-01-01)

Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
by: Mara Leyendecker, BS, et al.
Published: (2021-04-01)

Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease
by: Lung Chang, et al.
Published: (2021-07-01)

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease
by: Alessandra Marchesi, et al.
Published: (2021-01-01)

The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness
by: Tsung-Ju Yang, et al.
Published: (2018-06-01)

Heart and coronary artery damage related to Kawasaki syndrome
by: A. A. Leontyeva, et al.
Published: (2016-03-01)

Kawasaki disease: two case reports from the Aga Khan Hospital, Dar es Salaam-Tanzania
by: Mariam Noorani, et al.
Published: (2018-10-01)

Effect of different doses of aspirin on the prognosis of Kawasaki disease
by: Jinxin Wang, et al.
Published: (2020-06-01)

Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease
by: Hye Young Lee, et al.
Published: (2016-12-01)

Usefulness of Kawasaki disease risk scoring systems to the Turkish population
by: Kazım Öztarhan, et al.
Published: (2020-07-01)

Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease
by: Chun-Na Zhao, et al.
Published: (2016-01-01)

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase
by: Alessandra Marchesi, et al.
Published: (2018-08-01)

Review of Kawasaki Patients in Yazd
by: P Roozbeh, et al.
Published: (2009-01-01)

Kawasaki Disease in Children Older Than 10 Years: A Clinical Experience From Northwest India
by: Ankur Kumar Jindal, et al.
Published: (2020-02-01)

CLINICAL MANIFESTATION, DIAGNOSTICS AND TREATMENT OF KAWASAKI DISEASE: KNOWN DATA AND UNSOLVED QUESTIONS
by: G. А. Lyskina, et al.
Published: (2013-02-01)

Desquamation in Kawasaki Disease
by: Ling-Sai Chang, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_gavtqaijlh0hoe65b6vfi44ki5